Anonymous
Guest
Anonymous
Guest
I know a lot of people who work at Merck and it’s a shame. The first rule of management is to realize that the most important asset a company has is its people. It is understanding that some jobs may be gone because of duplicate positions after a merger but you are going overboard. You already have an experienced talent pool in place. That is extremely hard and time consuming to accomplish. The next logical step would be to use the people who are already there, increase the pipeline, get new drug approvals and make money. There is a much greater return on investment by keeping the people who make the company money over time. I almost think Merck bought SP for its patents and pipeline without having a long-term vision. People are the most important ingredient for a successful company. The best way to increase shareholder value is to make your own successful drugs. No company has ever made a penny by closing down buildings and consolidating. I know people are going to say that Merck is investing millions of dollars into a building there. That is 2 years away. I have done that for a company and the amount of overages and unexpected issues to overcome are overwhelming. 120 million dollars does not get you much in Jersey.